Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Glyphosate, a widely used herbicide in both agricultural and non-agricultural practices, has become pervasive in the environment, leading to significant human and animal exposure. Despite growing evidence of its potential endocrine-disrupting and reproductive toxicity, European regulatory agencies continue to affirm its safety. This study examines the effects of glyphosate on male reproductive health by exposing adult zebrafish to dietary glyphosate at doses within European safety thresholds. After 21 days of exposure, testicular samples were analysed using a combined approach involving transcript analysis, targeted metabolomics and proteomics, epigenetics, as well as immunohistochemistry. At 0.5 mg/kg body weight(bw)/day (the acceptable daily intake, ADI), glyphosate impaired germ cell differentiation and triggered cell-specific changes in histone acetylation within the male germline. Higher exposure levels of 50 mg/kg bw/day (the no observed adverse effect level, NOAEL) induced metabolomic and proteomic disruptions linked to impaired steroidogenesis, DNA damage in germ cells, and alterations in testicular architecture, culminating in reduced reproductive capacity. Interestingly, minimal testicular effects observed at 5 mg/kg bw/day highlighted the non-monotonic dose-response relationship to glyphosate. These findings unveil critical molecular and cellular disruptions caused by glyphosate and emphasize its potential reproductive risks, even at doses considered "safe" by regulatory standards. This research contributes to ongoing discussions surrounding sustainable agricultural practices and public health policies, calling for a re-evaluation of glyphosate safety thresholds.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.envint.2025.109544DOI Listing

Publication Analysis

Top Keywords

reproductive health
8
safety thresholds
8
glyphosate
7
reproductive
5
impact glyphosate
4
glyphosate regulatory
4
regulatory "safe"
4
"safe" levels
4
levels reproductive
4
health cellular
4

Similar Publications

GADD45A is Essential for Granulosa Cells Differentiation and Ovarian Reserve in Human and Mice.

J Cell Mol Med

September 2025

Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China.

Diminished ovarian reserve (DOR) poses significant challenges in reproductive health, with emerging evidence implicating DNA damage repair pathways. While GADD45A is a critical regulator of DNA repair, cell cycle and apoptosis, its role in DOR pathogenesis remains unexplored. We employed transcriptome sequencing, qPCR and Western Blot analyses to compare GADD45A expression in granulosa cells (GCs) between DOR patients and controls.

View Article and Find Full Text PDF

Access to contraceptive services during the COVID-19 pandemic: clients' perspective at primary health care level from India, Nigeria and Tanzania.

Reprod Health

September 2025

Department of Sexual and Reproductive Health including UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Avenue Appia 20, 1211, Geneva, Switzerland.

Background: The COVID-19 pandemic disrupted the provision of sexual and reproductive health services, including contraceptive and family planning (FP) services. The World Health Organization conducted a multi-country study in India, Nigeria and Tanzania to assess the impact of the pandemic on the health system's capacity to provide contraceptive and FP services. In this paper, we share the results of a qualitative study aimed at understanding clients' perspectives at the primary healthcare level on accessing contraceptive services in COVID-19-affected areas in the three aforementioned countries.

View Article and Find Full Text PDF

BackgroundIn 2023, a collaborative UNICEF-WHO group introduced the concept of small vulnerable newborns (SVNs) to improve the identification of newborns at increased risk of adverse outcomes and to guide more effective preventive strategies. However, global data on the prevalence of SVNs remains scarce. This study aimed to examine secular trends in the prevalence of SVNs and their three subgroups, namely term small for gestational age (SGA), preterm SGA, and preterm non-SGA, in the Japanese population.

View Article and Find Full Text PDF

Recent improvements in cell-free DNA technology have enabled non-invasive prenatal testing (NIPT) to screen for fetal single-gene autosomal recessive conditions from maternal blood as early as the first trimester. This technique can determine the fetal risk for cystic fibrosis (CF) with a single blood sample from a pregnant person without the need for a partner sample, which is required for traditional carrier screening. A retrospective review of 100,106 consecutive general-risk pregnant patients who underwent CF carrier screening was completed.

View Article and Find Full Text PDF

Bromuconazole, a widely used triazole-based pesticide, effectively controls fungal diseases in agriculture. Bromuconazole cause a potential toxic effect to non-target organisms and can have a negative impact on reproductive health in women, due to its long half-life and bioaccumulation ability. This study identifies the cytotoxicity and adverse effects of bromuconazole on trophoblastic cells (HTR-8/SVneo) and human endometrial cells (T HESCs), which are involved in implantation processes.

View Article and Find Full Text PDF